DHR Health Institute for Research & Development

McAllen, Texas 78504

0 studies enrolling now · 1 studies all time

What they study most

Cirrhosis, Liver, NASH

Studies at this site

• A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — Running, not enrolling